5-MAPB

What is 5-MAPB?

5-MAPB, short for 5-(2-Methylaminopropyl)benzofuran, is a synthetic compound belonging to the phenethylamine and amphetamine chemical classes. This research chemical has gained attention in scientific circles due to its structural similarity to MDMA (3,4-Methylenedioxymethamphetamine), commonly known as ecstasy.

Chemical Structure and Properties

5-MAPB features a benzofuran ring system connected to an alkyl aminopropane side chain. This unique molecular arrangement contributes to its Neurological activity. The compound exists as a white crystalline powder, typically in the form of hydrochloride salt. Its solubility in water and organic solvents makes it suitable for various research applications.

Pharmacological Profile

As a research chemical, 5-MAPB's pharmacological profile is not fully elucidated. However, studies suggest it acts primarily on the serotonin, dopamine, and norepinephrine systems. Its mechanism of action involves increasing the release and inhibiting the reuptake of these neurotransmitters, particularly serotonin. This activity pattern is reminiscent of MDMA, though with potentially distinct nuances in effect and duration.

Legal Status and Research Applications

The legal status of 5-MAPB varies globally, with many countries classifying it as a controlled substance. Its use is primarily restricted to scientific research, where it serves as a valuable tool for studying the effects of entactogens and the broader class of phenethylamines on brain chemistry and behavior.

Molecular Composition and Structure

5-MAPB, short for 1-(1-benzofuran-5-yl)-N-methylpropan-2-amine, belongs to the phenethylamine and amphetamine classes of compounds. Its chemical structure closely resembles that of MDMA (3,4-Methylenedioxymethamphetamine), with a benzofuran ring replacing MDMA's methylenedioxy ring. This subtle structural difference contributes to 5-MAPB's unique pharmacological profile.

Mechanism of Action

The primary mechanism of action for 5-MAPB involves its interaction with monoamine neurotransmitters in the brain. It acts as a potent releaser and reuptake inhibitor of serotonin, norepinephrine, and dopamine. This triple action on these key neurotransmitters is responsible for its Brain receptor activity.

Pharmacokinetics and Metabolism

5-MAPB undergoes metabolic processing primarily via the cytochrome P450 enzyme system in the liver, with metabolites excreted through urine. Laboratory studies have examined its pharmacokinetic profile, including absorption, metabolism, and excretion, under controlled experimental conditions..

Understanding the chemical structure and pharmacology of 5-MAPB is crucial for researchers investigating its potential applications and assessing its safety profile. However, it's important to note that as a research chemical, comprehensive long-term studies on its effects in humans are limited. DISCLAIMER: BY CONTINUING TO PURCHASE THE PRODUCT, THE CUSTOMER ACKNOWLEDGES AND AGREES THAT THIS PRODUCT IS NOT FOR HUMAN CONSUMPTION, DOES NOT CONSTITUTE MEDICINE, AND MUST NOT BE USED TO DIAGNOSE, TREAT, CURE, OR PREVENT ANY DISEASE, NOR TO ACHEIVE ANY OTHER EFFECTS ON THE HUMAN BODY. ALL RESEARCH CHEMICALS ARE OFFERED SOLELY FOR LIGITIMATE LABORATORY RESEARCH PURPOSES AND MAY STILL BE UNDERGOING SCIENTIFIC RESEARCH, TO DETERMINE THEIR SAFETY.